Aplastic anemia is a rare, life-threatening blood disorder where patients are unable to make enough blood cells due to the immune system's attack on blood stem cells. The condition can progress to ...
In this episode, MacDonald tackles a fundamental question that often overwhelms the newly diagnosed: Where exactly can cancer ...
Gaucher disease is a rare genetic disorder that causes the buildup of fatty substances in certain organs. Type 1 is the most common type of Gaucher disease, but it’s the least severe and has the most ...
Ana Lacerda, MD, MSc, of the Portuguese Institute of Oncology, advocates for early palliative care integration in pediatric patients with hematologic diseases. Improving end-of-life care for pediatric ...
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced risk for developing hematologic cancers compared with insulin and ...
Cardiovascular and oncologic outcomes of nivolumab + ipilimumab vs. pembrolizumab in malignant melanoma: A global real-world data analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
This chart illustrates the trends in ASIR and ASMR of major hematological malignancies, including HL, NHL, MM, and leukemia, across the world, China, and the United States from 1990 to 2021. Based on ...